文献速递心脑血管急症

急诊医师与远程神经科医师对急性缺血性卒中溶栓指征评估的一致性

Emergency Physician Versus Telemedicine Neurologist Assessment for Thrombolytic Indication in the Treatment of Acute Ischemic Stroke (AIS).
PubMed 文献 · Acad Emerg Med · 2025-07-04
一句话结论急诊医师与远程神经科医师对急性缺血性卒中溶栓指征的判断一致性为中等(κ=0.58),对溶栓禁忌原因的一致性为高度(κ=0.77)。

这项前瞻性观察研究在城市社区教学医院纳入92例症状疑似急性缺血性卒中且持续时间<4.5小时的成人急诊患者。急诊医师床旁评估后填写结构化表格,随后由远程神经科医师评估,比较两者对溶栓指征的判断一致性。结果显示,溶栓指征的总体一致率为86%(κ=0.58,中等),溶栓禁忌原因的一致率为83%(κ=0.77,高度)。在5.4%的病例中急诊医师认为有指征而远程神经科医师不同意且患者未接受溶栓,在9.8%的病例中急诊医师认为无指征而远程神经科医师认为应溶栓。

要点

  • 急诊医师与远程神经科医师对溶栓指征判断的一致率为86%(κ=0.58),属中等一致性。
  • 对溶栓禁忌原因判断的一致率为83%(κ=0.77),属高度一致性。
  • 5.4%(5例)病例急诊医师判断有溶栓指征但远程神经科医师不同意,患者未接受溶栓。
  • 9.8%(9例)病例急诊医师判断无溶栓指征但远程神经科医师认为应溶栓。
  • 3例患者尽管远程神经科医师认为有溶栓指征但未接受溶栓,其中1例急诊医师持不同意见。

适用人群与场景

  • 成人急诊患者,症状提示急性缺血性卒中且持续时间<4.5小时,来自城市社区教学医院的前瞻性便利样本。

研究设计与关键结果

  • 研究类型:前瞻性观察研究,单中心(城市社区教学医院),纳入92例成人急诊疑似急性缺血性卒中(症状<4.5小时)患者。
  • 人群特征:平均年龄61±15岁,女性47%,平均NIHSS 7±6,11%近3个月内有既往急性缺血性卒中,CT示颅内出血5%,8%从急诊离院回家,10%接受神经介入操作。
  • 溶栓治疗:18例(20%)接受了溶栓药物tPA。
  • 主要终点:急诊医师与远程神经科医师对溶栓指征判断的一致率为86%(κ=0.58,中等一致性)。
  • 次要终点:对溶栓禁忌原因判断的一致率为83%(κ=0.77,高度一致性)。
  • 不一致情况:5例(5.4%)急诊医师认为有溶栓指征而远程神经科医师不同意,患者未接受溶栓;9例(9.8%)急诊医师认为无溶栓指征而远程神经科医师认为应溶栓。
  • 3例患者尽管远程神经科医师认为有溶栓指征但未接受溶栓,其中1例急诊医师持不同意见。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:在该研究组中,急诊医师与远程神经科医师对溶栓指征判断的一致性为中等,对溶栓禁忌原因判断的一致性为高度。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND OBJECTIVES: Through the advent of telemedicine, ED patients in many smaller and rural hospitals have gained access to input from neurologists for the decision to provide thrombolytics (tPA) for AISCVA. We evaluated the interrater agreement between teleneurologists and emergency physicians (EP) for the indication to give thrombolytic tPA to ED patients with symptoms suggestive of AISCVA.

METHODS: This was a prospective, observational study conducted at an urban, community teaching hospital. A convenience sample of adult ED patient encounters for possible AISCVA symptoms < 4.5 h duration was included for analysis. Immediately following bedside evaluations, EPs filled out a structured form regarding their history, exam, and assessment of indications for thrombolytic tPA therapy. Subsequently, each patient was evaluated by a teleneurologist, and their assessment was recorded. Multivariate logistic regression was performed. Interrater agreement was assessed by 𝜅.

RESULTS: A total of 92 patients were enrolled; mean age 61 ± 15 years, 47% female, mean NIHSS 7 ± 6, 11% prior AISCVA past 3 months, intracranial hemorrhage on CT 5%, 8% discharged home from ED, 10% neurointerventional procedure. Thrombolytic tPA was received by 18 patients (20%). Agreement between EPs and teleneurologist for ± thrombolytic tPA indicated was moderate (86% agreement; 𝜅 = 0.58) and the reason for thrombolytic tPA ineligibility substantial (83% agreement; 𝜅 = 0.77). In five (5.4%) cases, the EP determined that thrombolytic tPA was indicated, the teleneurologist disagreed and the patient did not receive thrombolytic tPA. On the other hand, in nine (9.8%) cases, the EP felt thrombolytic tPA was not indicated and the teleneurologist assessed that it should be administered. For three cases, patients did not receive thrombolytic tPA despite the + teleneurologist impression that it was indicated, including one where the EP dissented.

CONCLUSION: Within our study group of patients evaluated for possible AISCVA, agreement between EP and teleneurologists for thrombolytic tPA indication was moderate and their agreement for thrombolytic tPA ineligibility reasons was substantial.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Linares N, Cambron J, Xu T, et al. Emergency Physician Versus Telemedicine Neurologist Assessment for Thrombolytic Indication in the Treatment of Acute Ischemic Stroke (AIS). Acad Emerg Med. 2025. PMID: 40613330. doi:10.1111/acem.70096

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。